Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer

NCT02384850 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasm

Interventions

DRUG: Selinexor
DRUG: Oxaliplatin
DRUG: 5-FU
DRUG: Folinic Acid

Sponsor

GSO Global Clinical Research BV

Collaborators

[object Object]